rs76394680

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001006630.2(CHRM2):​c.691G>A​(p.Val231Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00547 in 1,612,814 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V231A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0035 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 27 hom. )

Consequence

CHRM2
NM_001006630.2 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.87

Publications

11 publications found
Variant links:
Genes affected
CHRM2 (HGNC:1951): (cholinergic receptor muscarinic 2) The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine to these receptors and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 2 is involved in mediation of bradycardia and a decrease in cardiac contractility. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0066742003).
BP6
Variant 7-137015556-G-A is Benign according to our data. Variant chr7-137015556-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRM2NM_001006630.2 linkc.691G>A p.Val231Ile missense_variant Exon 4 of 4 ENST00000680005.1 NP_001006631.1 P08172A4D1Q0Q6SL56Q86SJ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRM2ENST00000680005.1 linkc.691G>A p.Val231Ile missense_variant Exon 4 of 4 NM_001006630.2 ENSP00000505686.1 P08172

Frequencies

GnomAD3 genomes
AF:
0.00346
AC:
525
AN:
151844
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.000585
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00425
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00556
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00343
AC:
856
AN:
249462
AF XY:
0.00332
show subpopulations
Gnomad AFR exome
AF:
0.00167
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00568
Gnomad EAS exome
AF:
0.000552
Gnomad FIN exome
AF:
0.00497
Gnomad NFE exome
AF:
0.00525
Gnomad OTH exome
AF:
0.00347
GnomAD4 exome
AF:
0.00568
AC:
8294
AN:
1460854
Hom.:
27
Cov.:
31
AF XY:
0.00537
AC XY:
3905
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.000987
AC:
33
AN:
33440
American (AMR)
AF:
0.00121
AC:
54
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.00475
AC:
124
AN:
26116
East Asian (EAS)
AF:
0.000608
AC:
24
AN:
39474
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86242
European-Finnish (FIN)
AF:
0.00445
AC:
237
AN:
53318
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5762
European-Non Finnish (NFE)
AF:
0.00670
AC:
7444
AN:
1111564
Other (OTH)
AF:
0.00615
AC:
371
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
565
1130
1696
2261
2826
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00345
AC:
525
AN:
151960
Hom.:
2
Cov.:
32
AF XY:
0.00310
AC XY:
230
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.00121
AC:
50
AN:
41484
American (AMR)
AF:
0.00177
AC:
27
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3466
East Asian (EAS)
AF:
0.000586
AC:
3
AN:
5120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00425
AC:
45
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00556
AC:
378
AN:
67928
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00464
Hom.:
5
Bravo
AF:
0.00290
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.00296
AC:
359
Asia WGS
AF:
0.000867
AC:
3
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 26, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val231Ile in exon 5 of CHRM2: This variant is not expected to have clinical si gnificance because it has been identified in 0.4% (299/65916) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs76394680). -

Oct 26, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dilated Cardiomyopathy, Dominant Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
21
DANN
Uncertain
0.97
DEOGEN2
Benign
0.053
T;T;T;T
Eigen
Benign
-0.10
Eigen_PC
Benign
0.099
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.79
.;.;.;T
M_CAP
Benign
0.0059
T
MetaRNN
Benign
0.0067
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.67
N;N;N;N
PhyloP100
2.9
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.18
N;N;N;N
REVEL
Benign
0.047
Sift
Benign
0.20
T;T;T;T
Sift4G
Benign
0.28
T;T;T;T
Polyphen
0.0010
B;B;B;B
Vest4
0.061
MVP
0.87
MPC
0.45
ClinPred
0.0079
T
GERP RS
5.4
Varity_R
0.16
gMVP
0.23
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76394680; hg19: chr7-136700303; COSMIC: COSV57764274; API